Healthcare
Exelixis is an oncology-focused biopharmaceutical company developing and commercializing cancer medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.
Read More
Evonik Health Care is Evonik’s pharmaceutical ingredients, drug-delivery and contract-manufacturing business. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.
Read More
Ergomed is a specialist CRO and pharmacovigilance services provider with a strong focus on rare disease, oncology, and complex clinical development programs. The company supports pharmaceutical and biotechnology sponsors through clinical trial management, regulatory support, safety services, and post-marketing pharmacovigilance.
Read More
Emmes Group is an established healthcare institution whose principal relevance to this ranking lies in clinical research across public-sector, biotech and rare-disease programs. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
Emergent BioSolutions is an established healthcare institution whose principal relevance to this ranking lies in preparedness vaccines, antibody therapies and manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Eli Lilly has become one of the most strategically important pharmaceutical companies in the world, driven by its leadership in diabetes and obesity medicines, alongside growing activity in oncology, immunology, neuroscience, and rare disease.
Read More
Eisai is an established healthcare institution whose principal relevance to this ranking lies in neurology, oncology and global prescription medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.
Read More
Editas Medicine is a gene editing company founded around CRISPR technology and has been active in ocular disease, hematology, and inherited disorders. Although the company has faced strategic shifts and competitive pressure, it remains a recognizable developer in the gene editing ecosystem.
Read More
Dyne Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in muscle-targeted oligonucleotide therapies for rare neuromuscular diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.
Read More
Dynavax Technologies is a vaccine-focused biopharmaceutical company whose principal relevance to this ranking lies in adjuvanted vaccines and immune-stimulation technology. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Delpharm is a contract development and manufacturing organization (CDMO) whose principal relevance to this ranking lies in European pharmaceutical development and contract manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.
Read More
Daiichi Sankyo is an established healthcare institution whose principal relevance to this ranking lies in global pharmaceutical companies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.
Read More
Curia Global is a contract research, development and manufacturing organization (CDMO) whose principal relevance to this ranking lies in drug discovery, development and commercial manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.
Read More
CureVac is an established healthcare institution whose principal relevance to this ranking lies in vaccine & immunotherapy developers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
CSL is a global biotechnology group supplying biotherapies, plasma products, influenza vaccines, and iron and nephrology medicines through CSL Behring, CSL Seqirus and CSL Vifor. Its origins date to 1916; CSL Limited was incorporated in 1991 and listed on the ASX in 1994.
Read More
CSL Seqirus is one of the world’s most important influenza vaccine developers and manufacturers. As part of CSL, the business benefits from biologics manufacturing expertise, global public health relationships, and strong experience in seasonal and pandemic influenza vaccine supply.
Read More
CSL Behring is one of the world’s leading specialty biologics companies, focused on plasma-derived therapies, immunoglobulins, hemophilia, hereditary angioedema, immunology, and rare diseases. Its business model is highly specialized, combining biologic manufacturing, plasma collection, global distribution, and specialist medicine.
Read More
CRISPR Therapeutics is one of the most important gene editing companies globally. Its partnership with Vertex on Casgevy established CRISPR editing as an approved therapeutic modality and marked one of the most important milestones in the history of genetic medicine.
Read More
CordenPharma is a contract development and manufacturing organization (CDMO) whose principal relevance to this ranking lies in integrated development and manufacturing for complex modalities. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.
Read More
Corcept Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in cortisol-modulation medicines and endocrine disease. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.
Read MorePagination
- First page
- Previous page
- …
- 15
- 16
- 17
- …
- Next page
- Last page